| Literature DB >> 33339475 |
Gianina-Ioana Postavaru1, Helen Swaby1, Rabbi Swaby2.
Abstract
BACKGROUND: There is a growing body of qualitative studies examining parents' experiences of caring for a child with a life-limiting condition, coinciding with recent evidence that indicates an increasing incidence of paediatric life-limiting conditions. However, research focusing on fathers' needs remains sparse and is often diluted among a predominant 'mother's voice', raising questions about whether practices in clinical settings meet fathers' needs. AIM: To provide an in-depth assembly of the current state of knowledge around fathers' experiences of caring for their children diagnosed with life-limiting conditions and understand the implications for healthcare services and policies.Entities:
Keywords: Palliative care; children; fathers; healthcare; life-limiting; meta-ethnography
Mesh:
Year: 2020 PMID: 33339475 PMCID: PMC7897781 DOI: 10.1177/0269216320979153
Source DB: PubMed Journal: Palliat Med ISSN: 0269-2163 Impact factor: 4.762
Study characteristics.
| Author, year and country | Participants n fathers | Response rate | Age range (years) | Source of participants | Data collection | Time of data collection | Children’s diagnosis | Children’s age | Children’s gender | Quality score |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaee et al., 2015, Iran | 5 fathers; 12 mothers | Not specified | 27–59 | Outpatient rehabilitation centre | Semi-structured interviews | During treatment | Cerebral palsy | 2.5–16 years | Not specified | 27 |
| Bailey-Pearce et al., 2017, UK | 7 fathers | 35% | 27–54 | Community paediatric nursing team | Interviews | At least one year since diagnosis | life-limiting condition | Under 18, not further specified | Not specified | 28 |
| Baird et al., 2016, USA | 2 fathers; 5 mothers | Not specified | 20 to >50 (incl. mothers) | Single PICU in urban, academic medical centre | Interviews, observation, & written materials | At least 7 days of hospital stay | Gastrointestinal chronic conditions (3); 2 genetic disorder; 1 seizure disorder; 1 heart disease | 2: <1; 2: 1–5; 2: 6–10; 1: 11–15 years | 4 male; 3 female | 27 |
| Brody et al., 2007, USA | 8 fathers | 100% | Not specified | Paediatric oncology clinic | Semi-structured interviews | During or within 1 year after treatm. | Cancer | 4–16 years ( | 2 female; 6 male | 28 |
| Cederborg et al., 2011, Sweden | 20 mothers & fathers | Not specified | Not specified | Not specified | Semi-structured interviews | At least 2 years post-diagnosis | Coeliac disease (CD) | 3–17 years | 12 female; 2 male | 23 |
| Chesler et al., 2001, USA | 167 fathers | Not specified | Not specified | Varied, including parent events | Interviews; group discussions | During or after treatment; after death | Cancer | Not specified | Not specified | 26 |
| Clarke, 2005, Canada | 16 fathers | Not specified | Support groups | Interviews | Within 5 years of treatment | Cancer | Not specified | 23 | ||
| Clarke-Steffen, 1993, USA | Fathers & mothers ( | Not specified | 22–45 (incl. mothers) | University hospital | Semi-structured interviews | 6 days to 5 months, 1 week post-diagnosis | Cancer | Toddler—school age | 3 male; 4 female | 25 |
| Cockle et al., 2016, UK | 3 fathers; 7 mothers | Not specified | 38–61 | Facebook page | Interviews | Post-PBT treatment | Brain tumour | 2–15 years | Not specified | 27 |
| Coons et al., 2016 (Part 1), Canada | 26 fathers; 58 mothers | n/a | 32–71 | Support organisation and agencies | Semi-structured interviews | Not specified | Fetal alcohol spectrum disorder (FASD) | 1 to 36 years, ( | Not specified | 24 |
| Coons et al., 2016 (Part 2), Canada | 14 fathers; 37 mothers | 100% | 36–71 | Agencies and online social media | Semi-structured interviews | Not specified | Fetal alcohol spectrum disorder (FASD) | 6–37 years ( | 58.49% female; 42.51% male | 24 |
| Dalvand et al., 2018, Iran | 1 father; 12 mothers | Not specified | 43 | Clinics and private rehabilitation centres | Semi-structured interviews | Not specified | Spastic quadriplegia | Not specified | Not specified | 27 |
| Davies et al., 2004, USA | 8 fathers | 53% | 34–39 years | Paediatric hospice home care | Unstructured interviews | 12–36 months post death | Cancer (5); spinal muscular atrophy (2); Tay Sachs (1) | 3 months to 14 years at death time | 4 male; 4 female | 30 |
| Dutta et al., 2020, Singapore | 6 couples; 13 lone mothers; 4 lone fathers (10 altogether) 2 parental figures | 87% | 30–79 | Hospice care, Children’s Cancer Foundation and Club Rainbow | Semi-structured interviews | 6 months-4 years post death (relevant to fathers’ experience) | 5 cancer; 1 brain tumour; 1 multiple diagn.; 1 spinal muscular atrophy; 1 kidney failure; 1 undisclosed | Not specified | Not specified | 30 |
| Eatough et al., 2013, Holland, Italy, Poland and Sweden | 1 father; 13 mothers | Not specified | Not specified | Clinical genetics or neurological services | Semi-structured interviews | Not specified | Juvenile Huntington’s disease | 9–24 years | 6 female; 8 male | 30 |
| Ellis et al., 2016, Australia | 34 fathers; 44 mothers | Not specified | 31–65 | Sydney Children’s Hospital | Semi-structured interviews | Cancer | 7–17 years | 25 male; 9 female | 26 | |
| Goble 2004, US | 5 fathers | Not specified | 29–41 | Local paediatrics office | Unstructured interviews | Not specified | Cerebral palsy (3); osteogenesis imperfect (1); autism (1) | 3–6 years | Not specified | 23 |
| Gómez-Ramírez et al., 2016, Canada | 10 fathers | Not specified | Not specified | Routine clinic visits in paediatric hospitals | Focus group & reciprocal interviews | 1st group: 9 months to 14 years since diag; 2nd group 2–6 months since diagnosis | Juvenile idiopathic arthritis | 2–16 years | 13 female; 6 male | 26 |
| Graffigna et al., 2013, Italy | 18 fathers; 30 mothers | Not specified | 39–65 (incl. mothers) | Neurological centres | Semi-structured interviews & online forum | At least 5 years post diagnosis | Tuberous, sclerosis complex | 1.5–22 years ( | 31 female; 17 male | 28 |
| Grossoeheme et al., 2012, USA | 5 fathers; 7 mothers | 71% | Not specified | Academic pediatric hospital | Semi-structured interviews | T1: >3 months after diagnosis.; T2: 1 year after 1st | Cystic fibrosis | 0.25–55 months at diagnosis (T1: 3 months of diagnosis) | 5 female; 2 male (only those who in 2nd interview) | 27 |
| Grossoehme et al., 2010, USA | 6 fathers; 9 mothers | 71% | Not specified | Academic pediatric hospital | Semi-structured interviews | During 1st year after diagnosis | Cystic fibrosis | 1 week to 55 months at diagnosis | 6 female; 3 male | 27 |
| Hayes et al., 2008, Ireland | 8 fathers | 80% | Not specified | CF center | Interviews | Not specified | Cystic fibrosis | 18 months to 6 years | All male | 27 |
| Hensler et al., 2013, Alabama | 25 fathers | 30% | Not specified | Survivor database at children’s hospital | Interviews | Within 1–10 years after treatment | Leukaemia (8); brain tumours (9); other cancers (8) | Younger than 18 years old | Not specified | 23 |
| Higgs et al., 2015, Australia | 6 fathers; 7 mothers | Not specified | Not specified | Victorian Clinical Genetics Services | Interviews | At least 18 months post-death | Spinal muscular atrophy (type 1) | N/A—age of death <3 months to 12 months | Not specified | 26 |
| Hill et al., 2009, Ireland | 5 biological fathers | Not specified | 31–42 | Not specified | Interviews | Within 2.5 years after treatment | Acute Lymphoblastic | 18 months to 7 years at time of diagnosis | Not specified | 27 |
| Ho et al., 2019, Singapore | 6 couples; 2 lone fathers (8 altogether); 12 lone mothers | 76% | 30–69 | Hospice, Children Cancer Foundation & Club Rainbow | Semi-structured interviews | 6 months to 4 years post death (relevant to fathers’ experience) | Cancer (5); brain tumour (1); kidney failure (1); spinal muscular atrophy (1) | Not specified | Not specified | 28 |
| Hobson et al., 2011, UK | 8 fathers | Not specified | Not specified | Community Nursing team | Interviews | Not specified | Complex health conditions | 16 months to 16 years | Not specified | 26 |
| Iversen et al., 2018, Norway | 8 mothers; 7 fathers | 83% | 26–40: mothers | Paediatric outpatient clinic | Interviews | At least 1 year since diagnosis | Type 1 diabetes | 1–7 years | Not specified | 30 |
| Jessup, 2009, Australia | 12 parents – N of fathers not specified | Not specified | Not specified | Regional CF clinic | Unstructured interviews | Medically stable, not on treatment | Cystic fibrosis | 2–21 years ( | 6 male; 3 female | 27 |
| Jones et al., 2003, USA | 7 biological fathers; 2 stepfathers; 1 grandfather | Not specified | 35–56 | Hospital based medical programme | 2 focus groups | During cancer treatment | Cancer | 3–16 ( | 5 male; 5 female | 24 |
| Jones et al., 2012, UK | 5 fathers; 6 mothers | Not specified | 55–76 | ‘Different Strokes’ charity | Semi-structured interviews | At least 12 months post-stroke | Stroke | 6 adult survivors 27–46 years | 4 female, 2 male | 26 |
| Kearney, 2001, Australia | 2 fathers; 4 mothers | Not specified | Not specified | Not specified | Interviews | Not specified | Brain damage (2); congenital impairments (1); Down’s synd. (1) | 3–6 years | 2 female; 2 male | 30 |
| Khoury et al., 2013, Lebanon | 2 fathers; 10 mothers | Not specified | 24–48 (incl. mothers); | Cancer Centre | Semi-structured interviews | 3 months to 6 years post-diagnosis | Cancer | 1–14.5 years | 6 male; 6 female | 28 |
| McGrath et al., 2004, Australia | 3 mothers; 1 father; 1 sibling; 3 diagnosed children | 97.5% | 40: father | Hospitals | Interviews | 2–3 months post diagnosis | Acute myeloid leukaemia | 0–16 years | 1 male; 2 female | 29 |
| McGrath et al., 2008, Australia | 3 fathers | 97.5% | Not specified | Hospital | Interviews | 2 months to 1 year post treatment | Cancer | 2–13 years at enrolment in study | Not specified | 26 |
| McNeill, 2004, Canada | 22 fathers | Not specified | 28-58 ( | Pediatric acute care hospital | Semi-structured interviews | Juvenile rheumatoid arthritis | Not specified | 28 | ||
| Mitchell et al., 2019, UK | 6 fathers; 11 mothers | 14% | Not specified | Paediatric intensive care unit | Semi-structured interviews | Approx. 11.8 months since bereavement | Life-limiting conditions | 5 months to 16 years | Not specified | 30 |
| Moola, 2012, Canada | 10 fathers; 19 mothers | Not specified | 35–55 | Outpatient clinics | Interviews | Not specified | Cystic fibrosis; Congenital heart disease | 10–18 years | Not specified | 28 |
| Neil-Urban et al., 2002, USA | 7 biological fathers; 2 stepfathers; 1 grandfather | Not specified | Not specified | Hospital based medical programme | 2 focus groups | During or within 4 months after treatment | Cancer | Not specified | Not specified | 18 |
| Newman et al., 2013, Canada | 5 fathers; 6 mothers | 50% | 33–55: fathers | Hospital for Sick Children (SickKids) | Interviews | >6 months post death | 7 with genetic or suspected genetic conditions | 4: 1–6 months | Not specified | 27 |
| Nicholas et al., 2009, Canada | 14 biological fathers; 1 adoptive; 1 stepfather | Not specified | 20–60; | Pediatric hospital | Semi-structured | During treatment | Cancer | 1–17 years | Not specified | 29 |
| Nicholas et al., 2016, Canada | 18 fathers | Not specified | Not specified | Pediatric hospitals | Interviews | At least 6 months post diagnosis | Diverse life-limiting conditions | 9–17 years | Not specified | 30 |
| Rankin, 2014, UK | 16 fathers | Not specified | 27–51 | Paediatric diabetes clinics | Semi-structured interviews | Not specified | Type 1 diabetes | 2–12 years | 24 male; 17 female | 27 |
| Rempel et al., 2012, Canada | 10 fathers; 15 mothers | Not specified | Not specified | Tertiary pediatric cardiac surgery program | Interviews | Not specified | Hypoplastic left heart syndrome | 6 months to 4.5 years | Not specified | 26 |
| Robinson et al., 2019 (Discovering Dad), USA | 10 fathers | 100% | Not specified | Paediatric/neonatal intensive care unit; hospital | Semi-structured interviews | Within 14 days of the surgery and approx.17 months after diagnosis | Complex cardiac conditions | 7 months-7 years ( | 8 males; 2 female | 29 |
| Robinson et al., 2019 (The Many Roles), USA | 4 fathers | 80% | Not specified | Palliative care unit | Interviews | During treatment | Neurological malignancy/brain tumours | 5–14 years ( | 2 male; 2 female | 29 |
| Schweitzer et al., 2012, Australia | 2 fathers; 9 mothers | 30% | 36–57 | Paediatric hospital | Semi-structured interviews | Not specified | Cancer | 8–16 years, ( | Not specified | 30 |
| Smith et al., 2015, UK | 10 fathers; 15 mothers | Not specified | 21–52 (incl. mothers); | Acute hospital & support group | Interviews | Not specified | Hydrocephalus | 2–13 years | 8 male; 7 female | 26 |
| Steele, 2002, Canada | 29 family members ( | Not specified | 28–48 years | Pediatric hospice care | Interviews & observations | 2.5–6 years post diagnosis | Neurodegenerative life-limiting condition | 3–13 years | 6 male; 4 female | 25 |
| Thienprayon et al., 2016, US | 2 fathers and 18 mothers | Not specified | Not specified | Children’s Medical Center | Semi-structured interviews | 3–7 years post-child’s death | Cancer | less than 2–18 years of age at death | 10 female; 10 male | 25 |
| Thomson et al., 2014, UK | 1 father; 7 mothers | Not specified | 30–59 | Specialist CAMHS | Semi-structured interviews | 4–30 months in CAMHS | Anorexia nervosa | 4: 11–14 years 4: 16–18 years | Not specified | 28 |
| Usher-Smith et al., 2013, UK | 50% | Not specified | Paediatric hospitals | Semi-structured interviews | Recently diagnosed | Type 1 diabetes | 2–15 years | 9 male; 7 female | 25 | |
| Verberne et al., 2017, Netherlands | 18 fathers; 24 mothers | Not specified | <30 to >40 (incl. mothers) | Paediatric palliative care team | Interviews | Pre- and post-child’s death | Life-limiting condition | 1: 0–1; 13: 1–5; 7: 5–12; 2: 12–16; 1: ⩾16 years | 12 female; 12 male | 27 |
| Verberne et al., 2019, Netherlands | 18 fathers; 24 mothers | 5 did not attend | <30 to >40 (incl. mothers) | Paediatric palliative care team | Semi-structured interviews | 2: 0–6 months | 15 non-malignant (congenital, neurodegenerat. and metabolic); 9 malignant diseases (CNS tumour; bone/soft tissue sarcoma, neuroblastoma; leukaemia) | 0–18 years | 12 male; 12 female | 28 |
| Waite-Jones et al., 2008, UK | 8 families (including healthy siblings and diagnosed children); 7 fathers; 8 mothers | Not specified | Not specified | Support group | Semi-structured interviews | Not specified | Juvenile idiopathic arthritis | 12–18 years | 4 male; 4 female | 28 |
| Wakefield et al., 2011, Australia | 15 fathers; 21 mothers | 34% | 43–65 | Sydney Children’s Hospital | Semi-structured interviews | Less than 5 years post-treatment | Cancer | 12–20 years ( | 13 male; 6 female | 25 |
| Ware et al., 2007, UK | 8 fathers | Not specified | Not specified | National newsletter, support groups; voluntary organisation | Semi-structured interviews | Not specified | Life-limiting condition | Not specified | Not specified | 30 |
| Wennick et al., 2006, Sweden | 11 fathers; 12 mothers | 100% | 30–52 | Child hospital | Interviews | Within 2 weeks of diagnosis | Diabetes | 7–14 years ( | 5 male; 7 female | 30 |
| West et al., 2015, Canada | 1 father; 1 male partner; 3 mothers | Not specified | Not specified | Family Nursing Unit | Interviews & clinical assessment | Approx. 4 years post intervention | Cancer | 7 years+ | Not specified | 26 |
| Wolff et al., 2011, USA | 15 fathers | 63% | 32–56 | Pediatric hospital | Semi-structured interviews | At least 6 months post diagnosis | Cancer (8); leukemia (4); sickle cell disease (3) | Not specified | Not specified | 26 |
| Woodgate et al., 2003, Canada | 39 children & their families— | Not specified | Not specified | Designated nurse intermediary | Observation & interviews | Not specified | Cancer | 4.5–18 years | 21 female; 18 male | 22 |
| Woodgate et al., 2004 Canada | Fathers & mothers ( | Not specified | Not specified | Not specified | Observation & interviews | Not specified | Cancer | 4½–18 years | 21 female; 18 male | 25 |
| Wright, 2017, UK | 3 fathers; 6 mothers | 50% | Not specified | Hospital | Semi-structured interviews | 5 pre-transfer to adult centre; 4 post-transfer | Chronic liver disease and acute liver failure | 15.2–25.1 years ( | 5 female; 4 male | 29 |
Figure 1.PRISMA flowchart.
Figure 2.Conceptual model.